Publication date: May 24, 2022
“The screening of patients for COLUMBUS-AD focuses on patients with surgically resected high-risk IIB-C BRAF V600E/K-mutant cutaneous melanoma”, said study coordinator assoc. It is estimated that 18% of stage IIB and 25% of stage IIC patients die from melanoma within 10 years from diagnosis. Available at: 2020 MELANOMA SKIN CANCER REPORT | Melanoma UK. What Causes Melanoma Skin Cancer. Van Akkooi, MD PhD, from the Melanoma Institute Australia (MIA) and past chairman of the EORTC Melanoma Group. 2020 Melanoma Skin Cancer Report. Accessed May 2021. International Agency for Research on Cancer.
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | Skin Cancer |
| drug | DRUGBANK | Coenzyme M |
| disease | MESH | actinic keratosis |
| disease | MESH | lung cancers |
| disease | MESH | development |
| pathway | KEGG | Colorectal cancer |
| disease | MESH | colorectal cancer |
| drug | DRUGBANK | Rasagiline |
| drug | DRUGBANK | Tropicamide |
| disease | MESH | DNA damage |
| disease | MESH | community |
| disease | MESH | biopsy |
| disease | MESH | diagnosis |
| drug | DRUGBANK | Nonoxynol-9 |
| disease | MESH | Cancer |
| pathway | KEGG | Melanoma |
| disease | MESH | melanoma |
| disease | MESH | recurrence |
| disease | MESH | metastasis |
| drug | DRUGBANK | Binimetinib |
| drug | DRUGBANK | Encorafenib |